Zinc lozenges: cold cure or candy? Solution chemistry determinations.

George A Eby

Journal: Bioscience reports 2004;24(1):23-39

PMID: 15499830

Free Full Text on PubMed Central View on PubMed

Abstract

Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and 2004, 10 other double-blind, placebo-controlled clinical trials showed widely varying results. This re-analysis of these trials presents solution chemistry methods to elucidate differences in efficacy. Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials.

Address: George Eby Research, Austin, Texas 78736, USA. [email protected]

DOI: 10.1023/b:bire.0000037754.71063.41

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/commoncold.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Cations, Common Cold, Dosage Forms, Drug Stability, Humans, Hydrogen-Ion Concentration, Ligands, Pharmaceutic Aids, Solutions, Time Factors, Zinc